These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7801991)

  • 1. Criteria for use of fluvoxamine maleate in adult inpatients and outpatients.
    Am J Hosp Pharm; 1994 Sep; 51(18):2282-5. PubMed ID: 7801991
    [No Abstract]   [Full Text] [Related]  

  • 2. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder.
    Marmar CR; Schoenfeld F; Weiss DS; Metzler T; Zatzick D; Wu R; Smiga S; Tecott L; Neylan T
    J Clin Psychiatry; 1996; 57 Suppl 8():66-70; discussion 71-2. PubMed ID: 8698684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report of successful treatment of bulimia nervosa with fluvoxamine.
    Spigset O; Pleym H
    Pharmacopsychiatry; 1991 Sep; 24(5):180. PubMed ID: 1775524
    [No Abstract]   [Full Text] [Related]  

  • 5. Compulsive buying and binge eating disorder--a case vignettes.
    Marcinko D; Bolanca M; Rudan V
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1542-4. PubMed ID: 16815617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambulatory use of G.34586 as a new antidepressive agent in therapy of endogenous forms with prevalence of anxiety].
    Vicini F; Tagliavini S
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Oct; 95(5):1002-18. PubMed ID: 5159715
    [No Abstract]   [Full Text] [Related]  

  • 8. [Depression and anxiety syndromes. Diagnostic and therapeutic aspects].
    Demel H
    Schweiz Rundsch Med Prax; 1970 Sep; 59(36):1266-72. PubMed ID: 5512662
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome and impact of mental disorders in primary care at 5 years.
    Jackson JL; Passamonti M; Kroenke K
    Psychosom Med; 2007 Apr; 69(3):270-6. PubMed ID: 17401055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Ueda N; Nakamura J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):452. PubMed ID: 17610677
    [No Abstract]   [Full Text] [Related]  

  • 12. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ataractic treatment in psychiatry and general medicine. Review of drugs. 5].
    Hertrich O
    Fortschr Med; 1983 Jul; 101(26):1250, 1252. PubMed ID: 6884962
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
    Barsky AJ; Orav EJ; Bates DW
    Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
    Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
    J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of psychoanalytic therapy].
    Rudolf G; Manz R; Ori C
    Z Psychosom Med Psychoanal; 1994; 40(1):25-40. PubMed ID: 8147138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.
    Cappiello A; McDougle CJ; Malison RT; Heninger GR; Price LH
    Biol Psychiatry; 1995 Dec; 38(11):765-7. PubMed ID: 8580232
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
    Lesaffre E; Molenberghs G; Dewulf L
    Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.